Patents by Inventor AURORE MORELLO

AURORE MORELLO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIFUNCTIONAL ANTI-PD1/IL-7 MOLECULES
    Publication number: 20240067727
    Abstract: The present invention relates to bifunctional molecules comprising an IL-7 variant and having a particular scaffold and their uses.
    Type: Application
    Filed: December 17, 2021
    Publication date: February 29, 2024
    Inventors: NICOLAS POIRIER, CAROLINE MARY, AURORE MORELLO, MARGAUX SEITE
  • BIFUNCTIONAL MOLECULES COMPRISING AN IL-7 VARIANT
    Publication number: 20230303648
    Abstract: The present invention relates to IL-7 variants, bifunctional molecules comprising it and their uses.
    Type: Application
    Filed: December 17, 2020
    Publication date: September 28, 2023
    Inventors: NICOLAS POIRIER, CAROLINE MARY, AURORE MORELLO
  • VACCINE AGAINST SARS-COV VIRUS
    Publication number: 20230181721
    Abstract: The present invention relates to a vaccine composition and its use against a Severe acute respiratory syndrome-related coronavirus.
    Type: Application
    Filed: May 11, 2021
    Publication date: June 15, 2023
    Inventors: DOMINIQUE COSTANTINI, ISABELLE GIRAULT, NICOLAS POIRIER, CAROLINE MARY, VANESSA GAUTTIER, AURORE MORELLO
  • BIFUNCTIONAL ANTI-PD-1/IL-7 MOLECULE
    Publication number: 20230071889
    Abstract: The present invention relates to a bifunctional molecule comprising an anti-PD-1 antibody and IL-7 and its uses.
    Type: Application
    Filed: December 17, 2019
    Publication date: March 9, 2023
    Inventors: NICOLAS POIRIER, CAROLINE MARY, AURORE MORELLO, JUSTINE DURAND
  • HUMANIZED ANTI-HUMAN-PD-1 ANTIBODY
    Publication number: 20220332826
    Abstract: Described herein are humanized anti-PD-1 antibodies, nucleic acids encoding such, and uses thereof in enhancing immune responses by activating T cells and treating diseases such as cancer and an infectious disease.
    Type: Application
    Filed: June 2, 2022
    Publication date: October 20, 2022
    Inventors: NICOLAS POIRIER, CAROLINE MARY, VIRGINIE THEPENIER, AURORE MORELLO, SABRINA PENGAM
  • Humanized anti-human-PD-1 antibody and its use in cancer treatment
    Patent number: 11352430
    Abstract: Described herein are humanized anti-PD-1 antibodies, nucleic acids encoding such, and uses thereof in enhancing immune responses by activating T cells and treating diseases such as cancer and an infectious disease.
    Type: Grant
    Filed: December 17, 2019
    Date of Patent: June 7, 2022
    Assignee: OSE IMMUNOTHERAPEUTICS
    Inventors: Nicolas Poirier, Caroline Mary, Virginie Thepenier, Aurore Morello, Sabrina Pengam
  • BIFUNCTIONAL ANTI-PD-1/SIRPA MOLECULE
    Publication number: 20220056135
    Abstract: The present invention relates to a bifunctional molecule comprising an anti-PD-1 antibody and SIRPa and its uses.
    Type: Application
    Filed: December 17, 2019
    Publication date: February 24, 2022
    Inventors: NICOLAS POIRIER, CAROLINE MARY, AURORE MORELLO, KEVIN BITEAU
  • BIFUNCTIONAL MOLECULE DIRECTED AGAINST HUMAN PD-1
    Publication number: 20220025050
    Abstract: The present invention provides a bifunctional molecule comprising a humanized anti-hPD-1 antibody or antigen binding fragment thereof linked to an immunotherapeutic agent able to specifically enhance the immune response and uses thereof.
    Type: Application
    Filed: December 17, 2019
    Publication date: January 27, 2022
    Inventors: NICOLAS POIRIER, CAROLINE MARY, VIRGINIE THEPENIER, AURORE MORELLO
  • HUMANIZED ANTI-HUMAN-PD-1 ANTIBODY
    Publication number: 20210355225
    Abstract: Described herein are humanized anti-PD-1 antibodies, nucleic acids encoding such, and uses thereof in enhancing immune responses by activating T cells and treating diseases such as cancer and an infectious disease.
    Type: Application
    Filed: December 17, 2019
    Publication date: November 18, 2021
    Inventors: NICOLAS POIRIER, CAROLINE MARY, VIRGINIE THEPENIER, AURORE MORELLO, SABRINA PENGAM